期刊文献+

肝或肾移植术后纤维化胆汁淤积性肝炎肝组织中CD4^+CD25^+调节性T淋巴细胞的表达 被引量:1

Detection of CD4^+CD25^+ regulatory T cells in liver tissues of fibrosing cholestatic hepatitis after liver and kidney transplantation
原文传递
导出
摘要 目的观察肝或肾移植术后纤维化胆汁淤积性肝炎(FCH)患者肝组织中CD4^+CD25^+调节性T淋巴细胞的表达及分布,并对其作用机制进行初步探讨。方法对5例FCH患者进行肝活体组织病理学检查;采用免疫组织化学法检测肝组织中CD4^+CD25^+调节性T淋巴细胞的特异性标记物叉状头/翅膀状螺旋回转录因子(FOXP3);采用末端脱氧核苷酸转移酶介导的脱氧三磷酸尿苷缺口末端标记(TUNEL)检测试剂盒对肝组织内的肝细胞凋亡情况进行观察。结果5例FCH患者中,3例为原位肝移植患者,2例为肾移植患者。光学显微镜下,肝脏汇管区及汇管区周围出现纤维化,肝细胞及胆小管明显胆汁淤积,肝细胞气球样变及毛玻璃样变。免疫组织化学检测显示HBsAg、HBcAg及前S1抗原阳性。FOXP3阳性信号定位于淋巴细胞胞质内,阳性细胞主要聚集在汇管区,小叶肝窦内可见散在的单个淋巴细胞呈阳性表达。汇管区周围可见较多的凋亡细胞。正常肝组织HBsAg、HBcAg及前S1抗原均为阴性,汇管区内有少量的阳性CD4^+CD25^+调节性T淋巴细胞,小叶内偶见凋亡细胞。结论FCH具有独特的组织学特征,可能与肝组织中的FOXP3高表达有关。 Objectives To study the expression and distribution of CD4^+CD25^+ regulatory T cells (Treg) in liver tissues of patients with fibrosing cholestatic hepatitis (FCH) after liver and kidney transplanta- tion and to investigate their roles in the pathogenesis of FCH. Methods Liver biopsy specimens from five patients with FCH were studied histopathologically. A specific marker for CD4^+CD25^+ regulatory T cells in those specimens was detected with anti-FOXP3 monoclonal antibody by immunohistochemistry. Apoptoses of hepatocytes were detected with in situ apoptosis detection TUNEL kit. Results Fibrosis in portal and around portal areas, cholestasis in some of the hepatocytes and canaliculi, widespread ballooning and groundglass appearance of liver cells, and positivity of HBsAg and HBcAg and Pre-S 1 protein were seen in the livers of all cases. The positive signal of FOXP3 was located in the cytoplasm of lymphocytes and the positive cells were mainly aggregated in the portal areas as well as occasionally appearing in the hepatic sinusoids. There were many more apoptotic hepatocytes near the portal areas. Conclusions Fibrosing cholestatic hepatitis has specific pathological characteristics which might be caused by high expressions of FOXP3 in liver tissues.
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2007年第9期667-671,共5页 Chinese Journal of Hepatology
关键词 病理学 T淋巴细胞 纤维化胆汁淤积性肝炎 Liver Pathology T lymphocytes Fibrosing cholestatic hepatitis
  • 相关文献

参考文献15

  • 1Yagi H, Nomura T, Nakamura K, et al. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int Immunol, 2004, 16: 1643-1656.
  • 2Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science, 2003, 299: 1057- 1061.
  • 3郎振为,马佩卿,赵红心,兰孟东,刀文彬,张亮,沈冰,石晓虹,马志春,王培之,张福杰.艾滋病相关淋巴结病理改变及其与淋巴结中CD4+CD25+调节性T细胞的相关性[J].中国医学科学院学报,2006,28(5):622-625. 被引量:8
  • 4陈嘉薇,陈大志,陈昭民,付红.肝移植术后纤维化胆汁淤滞性肝炎[J].中华器官移植杂志,2000,21(2):75-76. 被引量:3
  • 5Agarwal SK, Kalra V, Dinda A, et al. Fibrosing cholestatic hepatitis in renal transplant recipient with CMV infection: a case report. Int Urol Nephrol, 2004, 36: 433-435.
  • 6Jung S, Lee HC, Han JM, et al. Four cases of hepatitis B virus- related fibrosing cholestatic hepatitis treated with lamivudine. J Gastroenterol Hepatol, 2002, 17: 345-350.
  • 7Foo NC, Ahn BY, Ma X, et al. Cellular vacuolization and apoptosis induced by hepatitis B virus large surface protein. Hepatology, 2002, 36: 1400-1407.
  • 8卢建华,宋晨朝,郎振为,刘勇钢,王欣欣,闵福援,张世杰,孙琳,李俊强.前S1蛋白检测在慢性乙型肝炎患者病理诊断中的价值[J].中华传染病杂志,2006,24(1):60-62. 被引量:25
  • 9Stoop JN, van der Molen RG, Baan CC, et al. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology, 2005, 41:771-778.
  • 10Misra N, Bayry J, Lacroix-Desmazes S, et al. Cutting edge: human CD4^+CD25^+ T cells restrain the maturation and antigen-presenting function of dendritic cells. J Immunol, 2004, 172: 4676-4680.

二级参考文献41

共引文献68

同被引文献11

  • 1沈中阳.肝脏移植术后乙肝复发的综合防治[J].中国医学科学院学报,2005,27(4):431-434. 被引量:24
  • 2Tsai SL, Huang SN. T cell mechanisms in the immunopathogenesis of viral hepatitis B and C [ JJ. J Gastroenterol Hepatol, 1997, 12 (9 - 10) :S227-235.
  • 3Roncador G, Brown PJ, Maestre L, et al. Analysis of FOXP3 protein expression in human CD4 + CD25 + regulatory T ceils at the single-cell level [J]. EurJImmunol, 2005, 35(6): 1681-1691.
  • 4Fontenot JD, Rudensky AY. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription fac- tor Foxp3 [J]. Nat Immunol, 2005, 6(4): 331-337.
  • 5Camara NO, Sebille F, Lechler RI. Human CD4 + CD25 + regulatory cells have marked and sustained effects on CD8 + T cell activation [ J]. Eur J Immunol, 2003, 33 (12): 3473-3483.
  • 6Chen ML, Pittet MJ, Gorefik L. et al. Regulatory T cells suppress tumor- specific CD8T cell cytotoxicity through TGF beta signals in vivo [J]. Proc Natl Acad Sci U S A, 2005, 102(2) : 419-424.
  • 7Xu D, Fu J, Jin L, et al. Circulating and liver resident CD4 + CD25 + regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B [ J ]. J Immunol, 2006, 177(1 ) : 739-747.
  • 8Franzese O, Kennedy PT, Gehring AJ, et al. Modulation of the CD8 + -T-cell response by CD4 + CD25 + regulatory T ceils in patients with hepatitis B virus infection [ J]. J Virol, 2005, 79(6) : 3322-3328.
  • 9Stoop JN, van der Molen RG, Baan CC, et al. Resulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection [ J ]. Hepatology, 2005, 41 (4) : 771-778.
  • 10Pelletier SJ, Raymond DP, Crabtree TD, et al. Hepatitis C-induced hepatic allograft injury is associated with a pretransplantation elevated viral replication rate [ J ]. Hepatology, 2000, 32 (2) : 418-426.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部